# Liver-enriched Antimicrobial Peptide 2

> **NCT04043065** · EARLY_PHASE1 · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 10 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **BIOLOGICAL:** Liver-enriched antimicrobial peptide 2
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04043065
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-28
- **Primary completion:** 2019-05-20
- **Final completion:** 2019-05-20
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04043065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04043065, "Liver-enriched Antimicrobial Peptide 2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04043065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*